Apparently a Single Jab Will Do Ya

Published

Good news for a change for adults that is, kids might be a different story...

Although we'll be getting a further release of information tomorrow from the NIH, Dr. Anthony Fauci has signaled that US clinical trial data on the novel H1N1 vaccine matches that which was released earler today by Australia's CSL Ltd., which indicates that a single 15 microgram unadjuvanted shot produces good immune responses in adults over and under the age of 50.

Piling on the good news is that antibody titers reach protective levels in just 8 to 10 days after immunization, which is considerably sooner than had been expected.

All of this significantly loosens up tight vaccine supplies and lessens some of the logistics involved in getting the vaccine out into the arms of the population.

More at: http://afludiary.blogspot.com/2009/09/apparently-single-jab-will-do-ya.html

Specializes in Derm/Wound Care/OP Surgery/LTC.

Do we know what that time period is? Apparently, my pregnant daughters' ob/gyn doesn't know anything about it. It's frustrating that these docs aren't well enough informed about the virus let alone the vaccine. I've learned more from indigo girl and this forum than i have been able to from my own primary care doc.

Specializes in Too many to list.

Chery, I have read that you can have both the seasonal vax and swine at the same time in opposite arms although I probably would not do both together, myself. The seasonal vax is available right now.

The swine flu vax, we just heard today maybe available in early October instead of mid-October. There will be single dose syringes available without thimerosal . But, even though we have been told that it is possible to get the vax in this way, the problem will be in tracking down just where this type of vax is going to be given. It is mostly intended for kids which to me says that it won't be possible to get thimerosal free versions until almost November because kids are only a target group, not a priority group like pregnant women are. Priority groups will be vaxed first. Target groups come later. If she does not mind thimerosal, then she can get this as soon as it is available in October.

The info on the vaccines seems to change weekly so stay tuned as we get more info on drug trials and what they are finding.

I believe that these will be very safe vaccines. They are using the same technology as with the seasonal flu vaccines. Only the strain is different because this is a new virus.

The vaccine manufacturers and the govt officials have kids, and families too, just like us that they want to protect from the pandemic virus. They are being extremely careful with these vaccines. No one wants any problems.

Keeping in mind that pregnant women are high risk for adverse outcomes if infected with swine flu, I would prefer to see them safely vaccinated.

Specializes in Too many to list.

Four Swine Flu Vaccines Approved in the US

http://blog.al.com/live/2009/09/swine_flu_vaccine_approved_by.html

Four out of five are approved so far for the US population.

The Food and Drug Administration approved the new swine flu vaccine Tuesday, a long-anticipated step as the government works to get vaccinations under way next month.

Health and Human Services Secretary Kathleen Sebelius announced the vaccine's approval to Congress -- and said she hopes to get the first limited supplies distributed early in October.

The bulk of vaccine will start arriving Oct. 15, and Sebelius said it should be available at 90,000 sites around the country.

"We will have enough vaccine available for everyone" eventually, Sebelius said -- everyone who wants it, that is.

The government has ordered 195 million doses for now but may order more if needed, she said. Typically 100 million Americans seek flu vaccine every year.

But the vaccine, which protects against what doctors prefer to call the 2009 H1N1 flu strain, won't arrive all at once. About 45 million doses are expected by mid-October. That's why the government wants the people most likely to catch swine flu, and to suffer complications from it, to be first in line -- including children and pregnant women.

FDA licensure means that the government has certified the vaccine is made properly and meets specific manufacturing and quality standards. Separately, the National Institutes of Health is studying the vaccine dosage and safety. Last week, the NIH announced that one dose appears to protect adults -- and that that protection kicks in eight to 10 days after the shot.

Studies in children and pregnant women are continuing.

The vaccine approved Tuesday is made by CSL Ltd. of Australia; Switzerland's Novartis; Sanofi-Pasteur of France; and Maryland-based Medimmune, which makes the only nasal-spray flu vaccine.

+ Join the Discussion